help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schusdziarra, V.
Right arrow Articles by Unger, R. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schusdziarra, V.
Right arrow Articles by Unger, R. H.

Endocrinology, Vol 104, 1705-1708, Copyright © 1979 by Endocrine Society


ARTICLES

Evidence for a role of splanchnic somatostatin in the homeostasis of ingested nutrients

V Schusdziarra, V Harris, A Arimura and RH Unger

Somatostatin was infused via the portal vein at a rate of 50 ng/min in a group of eight conscious dogs beginning 30 min before and continuing for 6 h after the ingestion of an 800-g fat-protein meal. The fasting and postprandial levels of plasma somatostatin-like immunoreactivity (SLI), insulin, glucagon, and triglycerides were compared with those during an intraportal infusion of saline as a control. In both groups, SLI rose significantly within 15 min of the ingestion of the meal, but during somatostatin infusion, mean peripheral vein levels of SLI ranged from 30-85 pg/ml above those of the saline control experiments. The postprandial rise in plasma triglycerides was reduced significantly below the control values at all points between 75-270 min, and this reduction was the result of lowered chylomicron levels. Neither fasting nor postprandial insulin or glucagon levels were significantly reduced by the somatostatin infusion. Intraportally infused somatostain also reduced portal vein xylose levels after an intragastric xylose load. The results are compatible with, but do not prove, a physiological role for somatostatin in the homeostasis of ingested nutrients.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
F. Fery, L. Tappy, P. Schneiter, J. Deviere, and E. O. Balasse
Effect of Somatostatin on Duodenal Glucose Absorption in Man
J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4163 - 4169.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
V Schusdziarra, E Zyznar, D Rouiller, G Boden, J. Brown, A Arimura, and R. Unger
Splanchnic somatostatin: a hormonal regulator of nutrient homeostasis
Science, February 1, 1980; 207(4430): 530 - 532.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1979 by The Endocrine Society